What changed
$PANW — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ3 FY2026 (ends Apr) | reported Jun 02 | Rev $3.0B | EPS $0.32 vs $0.43 🔴 | Margin -6.1%
💡 Consensus expected continued strong growth and eventual profitability, but the -25.6% EPS miss and -6.1% operating margin indicate deteriorating fundamentals. The stock still trades at 237.7x trailing earnings, implying growth that is not materializing.
📉 Reward/risk: 5.0:1
🏢 Business Quality: 5/10
📊 Valuation: rich - Trailing P/E 237.7x, sector peer band 7.4x-46.2x, historical P/E 69.2x-170.8x (current at 171st percentile), DCF implies -14.4% FCF growth...
🔮 Catalyst: Next quarterly earnings report
💰 Entry: $304.2, stop $350.0, target $77.0
⚖️ Avoid PANW: -25.6% EPS miss, negative margins, and 237.7x P/E against a 75% downside to base valuation, with no clear positive catalyst.